1. Simultaneous Determination of Contents of Two Flavonols in the Aerial Parts of Echinops integrifolius by RP-HPLC
Chinese Pharmaceutical Journal 2018;53(2):136-139
OBJECTIVE: To establish an RP-HPLC analytical method for simultaneous determination of crysoeriol and centaureidin in the aeries parts of Echinops integrifolius. METHODS: The separation was achieved on a Kromasil C18 column (4.6 mm×250 mm, 5 μm)at 30℃ using acetonitrile-water-acetic acid solution (35∶65∶2) as mobile phase at a flow rate of 1.0 mL·min-1 and 350 nm as the detection wavelength. RESULTS: The linear ranges of crysoeriol and centaureidin were 0.4-2.4 mg·L-1(r=0.999 8), 0.6-2.6 mg·L-1 (r=0.999 9), respectively. The average recoveries (n=6) were 91.6% and 92.7%, and RSDs were 1.37% and 1.08% respectively. CONCLUSION: The methodology validation shows that this method is accurate, simple and reliable, which is applicable for the simultaneous determination of two flavonols crysoeriol and centaureidin in the aeries parts of Echinops integrifolius.
2.Chemical constituents of Pothos chinensis
Parygul BEISENHAN ; Tao ZHANG ; Bolat MAKABEL ; Zhong-Mei ZOU
Journal of International Pharmaceutical Research 2018;45(1):61-65
Obiective To investigate the chemical constituents of Pothos chinensis.Methods Compounds were isolated by the silica gel and Sephadex LH-20,semi-PHPLC,preparative thin layer chromatography and recrystallization.Structures of the com-pounds were identified by the physicochemical properties as well as the 1H NMR,13C NMR and MS spectroscopic data.Results Six-teen compounds were isolated from the whole plant of P.chinensis and their structures were identified as liquiritigenin(1),p-hydroxy-benzoic acid(2),syringic acid(3),E-4-hydroxycinnamic acid(4),N-trans-p-coumaroyltyramine(5),N-trans-cinnamoyltyramine (6),N-trans-feruloyltyramine(7),(+)-epiloliolide(8),neoechinulin A(9),vitexin(10),berchemolide(11),(±)-syringaresinol (12),prunasin(13),4-hydroxy-3,5-dimethoxybenzaldehyde(14),β-sitosterol(15)and β-daucosterol(16),respectively.Conclu-sion Compounds 1 and 9-14 are isolated from the genus Pohos for the first time.
3.Overview of application and research of Echinops genus in Chinese medicine.
Rozi PARHAT ; Bolat MAKABEL ; Ugulhan NURHABEK ; Amangul TOHONRBEK ; Hayni ; Fei-Fan SONG ; Asiya BAYSANBEK ; Hai-Yan YANG ; Gang DING ; Zhong-Mei ZOU
China Journal of Chinese Materia Medica 2014;39(19):3865-3869
Asteraceae Echionopos (Echinops genus) is one of the world's plants commonly used in traditional Chinese medicine herbs. In this paper, a lot of literature on the basis of domestic and foreign, and modern research on the application of medicinal plants in different ethnic groups in our country Echionopos made a brief presentation and evaluation, and its in Chinese Han, Mongolian, Uygur, Kazak, Korean and other ethnic groups in the application of traditional medicine and related research conducted profiles. To further comprehensive and accurate use of the abundant plant resources and research, in order to find biologically active natural products, provide reference basis for the clinical application of new drugs developed and expanded drug source.
Animals
;
Asteraceae
;
chemistry
;
Drug Therapy
;
Drugs, Chinese Herbal
;
chemistry
;
pharmacology
;
Humans
;
Medicine, Chinese Traditional
4.Usage of ethnomedicine on COVID-19 in China.
Zhi-Yong LI ; Ya TU ; Hai-Tao LI ; Jiang HE ; QUESHENG ; Guang-Ping DONG ; Ming-Shuo ZHANG ; Jian-Qin LIU ; Xiu-Lan HUANG ; Xiao-Rong WANG ; Makabel BOLAT ; Xin FENG ; Fang-Bo ZHANG ; Feng JIANG
China Journal of Chinese Materia Medica 2020;45(10):2265-2274
In December 2019, an outbreak of viral pneumonia began in Wuhan, Hubei Province, which caused the spread of infectious pneumonia to a certain extent in China and neighboring countries and regions, and triggered the epidemic crisis. The coronavirus disease 2019(COVID-19) is an acute respiratory infectious disease listed as a B infectious disease, which is managed according to standards for A infectious disease. Traditional Chinese medicine and integrated traditional Chinese and Western medicine have played an active role in the prevention and control of this epidemic. China's ethnomedicine has recognized infectious diseases since ancient times, and formed a medical system including theory, therapies, formula and herbal medicines for such diseases. Since the outbreak of the COVID-19 epidemic, Tibet Autonomous Region, Qinghai Province, Inner Mongolia Autonomous Region, Xinjiang Uygur Autonomous Region and Chuxiong Autonomous Prefecture of Yunnan, Qiandongnan Autonomous Prefecture of Guizhou have issued the prevention and control programs for COVID-19 using Tibetan, Mongolian, Uygur, Yi and Miao medicines. These programs reflect the wisdom of ethnomedicine in preventing and treating diseases, which have successfully extracted prescriptions and preventive measures for the outbreak of the epidemic from their own medical theories and traditional experiences. In this paper, we summarized and explained the prescriptions and medicinal materials of ethnomedicine in these programs, and the origin of Tibetan medicine prescriptions and Mongolian medicine prescriptions in ancient books were studied. These become the common characteristics of medical prevention and treatment programs for ethnomedicine to formulate therapeutic programs under the guidance of traditional medicine theories, recommend prescriptions and prevention and treatment methods with characteristics of ethnomedicine, and focus on the conve-nience and standardization. However, strengthening the support of science and technology and the popularization to the public, and improving the participation of ethnomedicine in national public health services and the capacity-building to deal with sudden and critical diseases are key contents in the development of ethnomedicine in the future.
Betacoronavirus
;
China
;
Coronavirus Infections
;
drug therapy
;
Humans
;
Medicine, Traditional
;
Pandemics
;
Pneumonia, Viral
;
drug therapy
;
Tibet